Oral misoprostol for the third stage of labor: A randomized controlled trial

Obstetrics and Gynecology

Volumn 101, Issue 5, 2003, Pages 921-928

  Çalişkan, Eray ^a   Dilbaz, Berna ^a   Meydanli, M Mutlu ^a   Öztürk, Nilgün ^a   Narin, Mehmet Ali ^a   Haberal, Ali ^a  

^a Dept of Obstetrics and Gynecology   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; METHYLERGOMETRINE MALEATE; MISOPROSTOL; OXYTOCIC AGENT; OXYTOCIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; HEMOGLOBIN DETERMINATION; HUMAN; INCIDENCE; LABOR; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIVERING; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOMITING;

EID: 17744412127     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200305000-00017     Document Type: Article

References (17)

1. World Health Organization. The global picture: The causes of maternal death. In: Abouzahr C, Royston E, eds. Maternal mortality: A global factbook. World Health Organization Geneva, 1991:7-11.
2. Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: An overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988;95:3-16.
3. El-Refaey H, Nooh R, O'Brien P, Abdalla M, Geary M, Walder J, et al. The misoprostol third stage of labour study: A randomised controlled comparison between orally administered misoprostol and standard management. Br J Obstet Gynaecol 2000;107:1104-10.
4. de Groot A, van Roosmalen J, van Bongen PW, Bormen GF. A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstet Gynecol Scand 1996;75:464-8.
5. El-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Misoprostol for third stage of labour. Lancet 1996;347:1257.
6. Walley RL, Wilson JB, Crane JMG, Mathews K, Sawyer E, Hutchens D. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. Br J Obstet Gynaecol 2000;107:1111-5.
7. Surbek DV, Fehr PM, Hosli I, Holzgreve W. Oral misoprostol for the third stage of labor: A randomized placebo-controlled trial. Obstet Gynecol 1999;94:255-8.
8. Amant F, Spitz B, Timmerman D, Corremans A, van Assche FA. Misoprostol compared with methylergometrine for the prevention of postpartum hemorrhage: A double-blind randomised trial. Br J Obstet Gynaecol 1999;106:1066-70.
9. Karim A. Antiulcer prostaglandin misoprostol: Single and multiple dose pharmacokinetic profile. Prostaglandins 1987;33 Suppl:40-50.
10. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92.
11. Choo WL, Chua S, Chong YS, Vanaja K, Oei PL, Ho LM, et al. Correlation of change in uterine activity to blood loss in the third stage of labour. Gynecol Obstet Invest 1998; 46:178-80.
12. Cook CM, Spurrett B, Murrey H. A randomised clinical trial comparing oral misoprostol with synthetic oxytocinor syntometrine in the third stage of labour. Aust N Z J Obstet Gynaecol 1999;39:414-9.
13. Pritchard JA, Baldwin RM, Dickey JC, Wiggings KM. Blood volume changes in pregnancy and the puerperium. Am J Obstet Gynecol 1962;84:1271-82.
14. Bloomfield TH, Gordon H. Reaction to blood loss at delivery. J Obstet Gynaecol 1990;10:S13-6.
15. American College of Obstetricians and Gynecologists. Postpartum hemorrhage. ACOG educational bulletin no. 243. Washington: American College of Obstetricians and Gynecologists, 1998.
16. Jaameri KE, Jaukola A, Pertu J. On shivering in association with normal delivery. Acta Obstet Gynecol Scand 1996; 45:383-8.
17. El-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Use of oral misoprostol in the prevention of postpartum hemorrhage. Br J Obstet Gynaecol 1997;104:336-9.